Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

US Approvals Analysis: April A Big Month For Non-Invasive Neurostim

May 05 2017

• By David Filmore

FDA approved background, 3D rendering, blue street sign

Related Content

US Approvals Analysis: Strong Month For IVD <em>De Novos </em>In February

Mar 07 2017

23andMe Opens Up FDA Pathway For DTC Genetic Predisposition Tests

Apr 06 2017

ElectroCore's gammaCore Gets US Clearance For Cluster Headaches

Apr 18 2017

ElectroCore Aims To Bring Neurostimulation To The Masses, Beginning With Headache

Sep 16 2013

Electroceuticals: Drug-Like Effects, Without The Drugs

Feb 19 2015

Related Companies

ElectroCore, Inc.

Allergan plc

Allergan, Inc.

Merck & Co., Inc.

23andMe, Inc.

Royal Philips

Novartis AG

Invivoscribe Technologies, Inc.

Medtronic plc

C.R. Bard

Additional Topics

United States Approvals Innovation Medical Device In Vitro Diagnostics

More from Approvals

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window